Drug Shortage Report for POTASSIUM CHLORIDE INJECTION
Report ID | 98262 |
Drug Identification Number | 02241679 |
Brand name | POTASSIUM CHLORIDE INJECTION |
Common or Proper name | POTASSIUM CHLORIDE INJECTION |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CHLORIDE |
Strength(s) | 29.8MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 50 mL (JB0822) |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-11-08 |
Actual start date | 2019-11-08 |
Estimated end date | 2019-11-28 |
Actual end date | 2019-11-28 |
Shortage status | Resolved |
Updated date | 2019-11-29 |
Company comments | Consult local pharmacy to find clinical alternatives. Alternative concentrations/doses are available including 10 mmol Potassium Chloride in 50 mL Sterile Water for Injection (Code: JB0821P, DIN: 02241677). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-08 | English | Compare |
v2 | 2019-11-08 | French | Compare |
v3 | 2019-11-09 | English | Compare |
v4 | 2019-11-28 | English | Compare |
v5 | 2019-11-28 | French | Compare |
v6 | 2019-11-29 | English | Compare |
Showing 1 to 6 of 6